依洛尤单抗在孤立性心脏移植的家族性高脂血症中的应用。
Use of Evolocumab in Familial Hyperlipidemia With Isolated Heart Transplant.
作者信息
Mackenzie Colin, Anderson McHale, Shah Kevin S
机构信息
Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Division of Cardiovascular Medicine, University of Utah, Salt Lake City, Utah, USA.
出版信息
JACC Case Rep. 2024 Aug 7;29(15):102426. doi: 10.1016/j.jaccas.2024.102426.
We describe a novel use of evolocumab for successful postoperative lipid control in a patient with familial hyperlipidemia who underwent isolated heart transplantation. We believe that this case carries valuable lessons regarding post-transplant proprotein convertase subtilisin kexin 9 inhibitor use with implications for the future of combined organ allocation and transplantation waitlist times.
我们描述了依洛尤单抗在一名接受单纯心脏移植的家族性高脂血症患者术后成功控制血脂方面的新用途。我们认为，该病例对于移植后前蛋白转化酶枯草溶菌素9抑制剂的使用具有宝贵的借鉴意义，对未来联合器官分配和移植等待时间也有启示。
Zotero 插件